Tai chi Qigong improves lung functions and activity tolerance in COPD clients: a single blind, randomized controlled trial

Complement Ther Med. 2011 Feb;19(1):3-11. doi: 10.1016/j.ctim.2010.12.007. Epub 2011 Jan 17.

Abstract

Objective: To evaluate the effectiveness of a Tai chi Qigong (TCQ) program in enhancing respiratory functions and activity tolerance in clients with chronic obstructive pulmonary disease (COPD).

Design: A single-blind, randomized controlled trial.

Setting: Five general outpatient clinics in Hong Kong.

Intervention: In total, 206 COPD clients were randomly assigned into one of the three groups, namely, TCQ, exercise, and control group. Subjects in the TCQ group received a TCQ program consisting of two 60-min sessions each week for three months. Subjects in the exercise group were taught to practice breathing techniques combined with walking as an exercise. Subjects in the control group were instructed to maintain their usual activities. Data collection was performed at baseline and at the 6-week and 3-month marks.

Outcomes: Lung functions, 6-min walk test, and COPD exacerbation rate.

Results: Results of repeated measures of analysis of covariance demonstrated that there were significant interaction effects between time and group in forced vital capacity (p=.002, η(2)=.06), forced expiratory volume in 1s (p<.001, η(2)=.02), walking distance (p<.001), and exacerbation rate (p=.006, η(2)=.06) at 3 months. Improvements were noted in the TCQ group. No changes were observed in the exercise group, while a decline in lung functions was noticed in the control group.

Conclusion: Tai chi Qigong was able to improve respiratory functions and activity tolerance level in COPD clients. The breathing and walking exercise helped maintain lung functions and slow down disease progression.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Breathing Exercises*
  • Exercise Test
  • Exercise Therapy
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Single-Blind Method
  • Spirometry
  • Tai Ji*
  • Treatment Outcome